Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

394 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Active, Not Recruiting

NCT03147885

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +35 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Active, Not Recruiting

NCT03015896

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT04464200

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States

Active, Not Recruiting

NCT04072458

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations: Georgia Cancer Center Augusta, Georgia, United States

New York Medical College / Westchester Medical Center Valhalla, New York, United States

Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States

University of Texas Southwestern Medical Center Dallas, Texas, United States